documents: FDA-1975-N-0012-0025
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-1975-N-0012-0025 | FDA | FDA-1975-N-0012 | Tab E - "Alcavis International, Inc., Letter to FDA, March 18, 2003" - [Alcavis, International, Inc., (Buchanan Ingerson and Rooney PC) | Supporting & Related Material | Background Material | 2009-12-22T05:00:00Z | 2009 | 12 | 2017-11-29T20:35:48Z | 0 | 0 | 0900006480a4d2b1 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref